Suplasin, 10mg/ml syringe 2ml 1pc

Suplazine contains hyaluronic acid. Hyaluronic acid is a physiological component of synovial fluid and plays a major role in supporting and lubricating the joint.

Indications

Synovial fluid replacement after arthrocentesis, osteoarthritis.

SUPLASIN is used in osteoarthritis to treat pain and improve joint function because the drug improves the rheological properties of synovial fluid.

Active ingredient

Composition

1 syringe contains:

the active ingredients:

Hyaluronic acid sodium salt 20 mg,

Phosphate buffer 2 ml.

How to take, the dosage

Depending on the size of the joint, up to 2 ml of SUPLASIN can be applied intra-articularly.

The standard recommended dosing regimen is a weekly injection of the drug for 3 weeks, but therapy may be continued for up to 6 weeks if the process is chronic.

In aseptic conditions, up to 2 ml of the drug is injected intra-articularly into the affected joint. Multiple joints may be treated with SUPLASIN at the same time. Any unused residual product in the vial or syringe must be disposed of.

Special Instructions

Observe the usual precautions and contraindications for any intra-articular injections.

Intravascular injections are prohibited.

Suplasin should not be administered to patients with joint inflammation/inflammation because adverse events are more likely to occur in patients with pre-existing joint inflammation/inflammation.

Because there are no clinical data on the treatment of children, pregnant and lactating women with hyaluronic acid, treatment with Suplazine is not recommended for these patients.

Prevent the administration of Suplasin using instruments sterilized with quaternary ammonium hydroxide solution.

The patient should be at rest for 24-48 hours after injection and avoid all physical activity for the duration of treatment.

Transient transient pain may occur following an intra-articular injection. The joint in question may exhibit mild local reactions such as pain, burning sensation, overheating, redness, effusion, irritation, and swelling/inflammation. If these symptoms are present, immobilize affected joint and apply ice locally.

In most patients, these symptoms go away within a few days. In some cases, namely hypersensitivity, mild local reactions such as pain, irritation, joint swelling/inflammation, and effusion may be much longer and more severe. In such cases, curative measures such as aspiration of synovial fluid may be necessary.

Local adverse reactions may be accompanied by general body reactions such as fever, chills or cardiovascular reactions, and in rare cases, anaphylactic reactions.

In extremely rare cases, rash/rash, urticaria, synovitis and a drop in blood pressure after administration of Suplazine have been reported. If adverse reactions occur, the drug should be discontinued.

Contraindications

Hypersensitivity to the active ingredients or excipients of the drug.

Side effects

Transient pain may occur with intra-articular injections.

Little local reactions in the form of pain, fever, redness and swelling may occur.

In a few days, these reactions disappear on their own.

In rare cases, hypersensitivity reactions in the form of more severe local reactions and/or increased body temperature have occurred.

In the event of significant adverse reactions, therapy with SUPLASIN should be discontinued.

Similarities